Ocular Therapeutix (OCUL) Reports Q4 Revenues Below Estimates

March 8, 2018 7:32 AM

Note: EPS may not be comparable

Ocular Therapeutix (NASDAQ: OCUL) reported Q4 EPS of $, versus ($0.52) reported last year. Revenue for the quarter came in at $487 thousand versus the consensus estimate of $520 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.


Earnings Guidance

Next Articles